Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke

被引：9
|
作者：
Hallevi, Hen [1 ]
Grotta, James C. [1 ]
机构：
[1] Univ Texas Houston, Vasc Neurol Program, Houston, TX 77030 USA
来源：
ARCHIVES OF NEUROLOGY | 2008年 / 65卷 / 05期
关键词：
D O I：
10.1001/archneur.65.5.575
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：575 / 576
页数：2
相关论文
共 50 条
  • [1] Aortic Transgraft Hemorrhage after Intravenous Tissue Plasminogen Activator Therapy in Patients with Acute Ischemic Stroke
    Kawano, Tomohiro
    Kajimoto, Katsufumi
    Higashi, Masahiro
    Minatoya, Kenji
    Toyoda, Kazunori
    Nagatsuka, Kazuyuki
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (08): : 2145 - 2150
  • [2] Does Prestroke Antiplatelet Therapy Increase the Risk of Symptomatic Intracranial Hemorrhage in Patients Receiving Tissue Plasminogen Activator for Acute lschemic Stroke?
    Owyang, Clark G.
    Lay, Cappi
    [J]. ANNALS OF EMERGENCY MEDICINE, 2018, 71 (03) : 416 - 418
  • [3] Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator
    Menon, Bijoy K.
    Saver, Jeffrey L.
    Prabhakaran, Shyam
    Reeves, Mathew
    Liang, Li
    Olson, DaiWai M.
    Peterson, Eric D.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    Schwamm, Lee H.
    Smith, Eric E.
    [J]. STROKE, 2012, 43 (09) : 2293 - +
  • [4] Sonothrombolysis: An effective adjunct to intravenous tissue plasminogen activator therapy in acute ischemic stroke
    Miyachi, Shigeru
    [J]. NEUROLOGY INDIA, 2017, 65 (01) : 20 - 21
  • [5] Early antiplatelet therapy used for acute ischemic stroke and intracranial hemorrhage
    Buddhavarapu, Venkata
    Kashyap, Rahul
    Surani, Salim
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (04)
  • [6] Analysis of the risk of hemorrhagic complications in acute ischemic stroke patients with microbleeds after intravenous recombinant tissue plasminogen activator therapy
    Takahashi, Y.
    Morihara, R.
    Narai, H.
    Omori, N.
    Manabe, Y.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 57 - 58
  • [7] Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator
    Xian, Ying
    Federspiel, Jerome J.
    Grau-Sepulveda, Maria
    Hernandez, Adrian F.
    Schwamm, Lee H.
    Bhatt, Deepak L.
    Smith, Eric E.
    Reeves, Mathew J.
    Thomas, Laine
    Webb, Laura
    Bettger, Janet Prvu
    Laskowitz, Daniel T.
    Fonarow, Gregg C.
    Peterson, Eric D.
    [J]. JAMA NEUROLOGY, 2016, 73 (01) : 50 - 59
  • [8] Intravenous thrombolytic therapy for acute ischemic stroke - Weighing the risks and benefits of tissue plasminogen activator
    Koller, RL
    Anderson, DC
    [J]. POSTGRADUATE MEDICINE, 1998, 103 (04) : 221 - +
  • [9] Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: Initial Israeli experience
    Schwammenthal, Y
    Drescher, MJ
    Merzeliak, O
    Tsabari, R
    Bruk, B
    Feibel, M
    Hoffman, C
    Bakon, M
    Rotstein, Z
    Chapman, J
    Tanne, D
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (02): : 70 - 74
  • [10] Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator
    Xian, Ying
    Liang, Li
    Smith, Eric E.
    Schwamm, Lee H.
    Reeves, Mathew J.
    Olson, DaiWai M.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    Peterson, Eric D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (24): : 2600 - 2608
12345